Redsense Medical AB (publ)
RDSNF
$0.51
-$0.54-51.43%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 95.92% | 102.87% | -4.37% | 46.40% | -12.04% |
| Total Depreciation and Amortization | 3.28% | 8.62% | 10.71% | 12.96% | 19.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 121.95% | 32.53% | -168.77% | -350.23% | -1,275.16% |
| Change in Net Operating Assets | -373.39% | -816.72% | -91.27% | -636.42% | 203.32% |
| Cash from Operations | 48.63% | -64.70% | -134.43% | -138.64% | 3.05% |
| Capital Expenditure | 67.35% | 67.35% | 82.98% | 82.98% | -8.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -141.09% | -106.94% | -80.88% | -84.97% | -80.59% |
| Cash from Investing | -143.55% | -107.19% | -80.85% | -84.99% | -81.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | 2,792.70% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 285.10% | 145.33% | 221.49% | -145.74% | -1,930.23% |